Published by ODA3 InstituteDocs / GAISSF™ / Sector guidance
GAISSF™ Pharmaceutical Sector Executive Primer
ID SEC-049A
Framework GAISSF™ Type Sector guidance
Scope and limitsNo universal global regulatory classification or validation method for pharmaceutical AI is assumed. Model accuracy alone is not treated as evidence of clinical, safety, quality or regulatory fitness.
Revision history
| Date (as stated) | Event | What changed |
|---|---|---|
| 5 October 2026 | Document revision | Draft for Publication issued; external review openSource: GAISSF-SEC-049A_Pharmaceutical_Executive_Primer_v1.0.pdf |
Website record last updated 7 October 2026. This is the web page, not the document.
More from GAISSF™
| SEC-047 | GAISSF™ Telecommunications Sector Implementation Guide |
| NOR-001 | GAISSF™ Framework Standard |
| NOR-002 | GAISSF™ Executive Summary |
| NOR-003 | GAISSF™ Quick Start Guide |
Cite this document
ODA3 Institute. GAISSF™ Pharmaceutical Sector Executive Primer (SEC-049A), v1.0. Published 1 July 2026. docs.oda3.org/documents/sec-049a/
ODA3 Institute. GAISSF™ Pharmaceutical Sector Executive Primer (SEC-049A), v1.0. Published 1 July 2026. docs.oda3.org/documents/sec-049a/